To further examine the ability of asporin to enhance tumor progression in thyroid cancer, we knocked down endogenous asporin expression in thyroid cancer cell lines by transfection with three siRNAs (Figures 4A, B). This evidence concerns the gene ASPN and thyroid gland carcinoma.